The company has received a Medical Device Registration Certificate from the National Medical Products Administration for its Helicobacter pylori antigen detection kit. This Class III product is intended for in vitro qualitative detection of H. pylori antigens in human feces. The registration enhances the company's technological innovation and compliance capabilities, broadening its product range and market access, which positively impacts future development. Investors are advised to consider potential market uncertainties.
Summary generated by AI · Always verify with source document
Kefu Medical Technology Co., Ltd. (hereinafter referred to as "the Company") has recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The specific details are as follows:
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.